 |
Depósito mínimo $50 Promoção exclusiva |
Nossa pontuação |
0% comissão |
Are you looking to buy NuVasive stocks? Chech our Reportlab with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:NUVA! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about NuVasive stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
NuVasive, Inc., a medical device company, develops and markets minimally disruptive surgical products and procedurally integrated solutions for spine surgery. Its products focus on applications for spine fusion surgery, including ancillary products and services used to aid in the surgical procedure. The company’s principal products include Maximum Access Surgery, a minimally disruptive surgical platform, which includes its software-driven nerve detection and avoidance systems, and intraoperative monitoring (IOM) services and support; MaXcess, an integrated split-blade retractor system; and various specialized implants and biologics. Its spine surgery product line offerings comprises products for the thoracolumbar and the cervical spine, which are primarily used to enable surgeons to access the spine to perform restorative and fusion procedures in a minimally disruptive fashion. The company’s biologics products include Osteocel Plus and Pro, a cellular bone matrix; Formagraft, a collagen-based synthetic bone substitute; AttraX, a synthetic bone graft material; and Propel DBM, a moldable demineralized bone matrix putty and gel. Its IOM services are used for onsite and remote monitoring of the neurological systems of patients undergoing spinal and brain-related surgeries. The company also provides implants used for interbody disc height restoration; and fixation products, including pedicle screws, rods, and plates. In addition, it offers Integrated Global Alignment platform for assessing, preserving, and restoring spinal alignment; MAGEC-early onset scoliosis, a spinal bracing and distraction system; and Precice, a limb lengthening system. The company sells its products to patients, surgeons, hospitals, and insurers through independent sales agents, directly-employed sales personnel, and distributors in the United States and internationally. NuVasive, Inc. was founded in 1997 and is headquartered in San Diego, California.
Volume médio
859,900 shs
MERCADO CAP
$3.00 billion
Bolsa de Valores
NASDAQ
Comprem essas ações!
|
NOME
|
TICKER
|
INDÚSTRIA
|
SECTOR
|
VOLUME
|
COMPRAR AGORA ESSAS AÇÕES
|
|---|---|---|---|---|---|
|
NASDAQ: NUVA
|
Instrumentos cirúrgicos e médicos
|
Médico
|
11,309 shs
|
Below is a quick guide on how to buy NASDAQ:NUVA stocks safe, fast and around the world in less than five minutes.
Passo 1: Abrir uma conta no eToro – eToro is the best broker to buy NuVasive shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Passo 2: Carregue sua identificação - Conforme os regulamentos da KYC, eToro lhe pedirá que carregue uma cópia de seu passaporte ou de sua carteira de motorista.
Etapa 3: Fundos de depósito - Deposite algum dinheiro em sua recém-criada conta eToro. O senhor pode escolher entre transferência bancária, carteira eletrônica, cartão de débito/crédito ou Paypal.
Passo 4: Buy NuVasive – Search for “”NASDAQ:NUVA”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought NuVasive stocks with 0% commission!.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
17 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for NuVasive in the last twelve months. There are currently 2 sell ratings, 8 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should “hold” NuVasive stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NUVA, but not buy additional shares or sell existing shares.
Wall Street analysts have given NuVasive a “Hold” rating, but there may be better short-term opportunities in the market. Some of Reportlab’s past winning trading ideas have resulted in 5-15% weekly gains. Reportlab just released five new trading ideas, but NuVasive wasn’t one of them. Reportlab thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
2 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
3 |  | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:NUVA stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy NuVasive stocks with a step by step approach.
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy NuVasive stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Como o eToro é uma plataforma regulamentada, o senhor precisará completar o processo KYC, isso é uma prática padrão e leva apenas alguns minutos. O senhor precisará fornecer um documento de identificação com foto (passaporte, carteira de motorista) e comprovante de endereço (conta de serviços públicos, extrato bancário).
Uma vez que o senhor tenha se inscrito e verificado sua conta, precisará depositar fundos. eToro aceita cartões de crédito/débito, transferências bancárias, e também carteiras eletrônicas. Portanto, qualquer que seja sua preferência, haverá algo para o senhor.
Now that you’ve funded your eToro account, just type “NASDAQ:NUVA stocks” na barra de busca na parte superior da tela e pressione "trade".
All that’s left is to buy some NASDAQ:NUVA stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
All in all, NASDAQ:NUVA is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy NuVasive stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
NuVasive is scheduled to release its next quarterly earnings announcement on Thursday, February 18th 2021.
View our earnings forecast for NuVasive.
NuVasive, Inc. (NASDAQ:NUVA) posted its quarterly earnings data on Thursday, October, 29th. The medical device company reported $0.55 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.24 by $0.31. The medical device company earned $295.30 million during the quarter, compared to analysts’ expectations of $257.70 million. NuVasive had a negative net margin of 0.84% and a positive trailing twelve-month return on equity of 8.00%. NuVasive’s revenue was up 1.5% compared to the same quarter last year. During the same period last year, the company posted $0.59 EPS.
View NuVasive’s earnings history.
NuVasive’s stock was trading at $49.41 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, NUVA stock has increased by 18.6% and is now trading at $58.61.
17 equities research analysts have issued 12-month price targets for NuVasive’s shares. Their forecasts range from $48.00 to $85.00. On average, they anticipate NuVasive’s share price to reach $62.00 in the next twelve months. This suggests a possible upside of 5.8% from the stock’s current price.
View analysts’ price targets for NuVasive or view top-rated stocks among Wall Street analysts.
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:NUVA stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
Mais de 95% de fundos de clientes são mantidos offline, em câmara fria, o que é crucial para qualquer corretor que administre seus ativos. Independentemente de quão segura deve ser uma plataforma, recomendamos o uso do 2FA para acrescentar uma camada adicional de segurança à sua conta.
eToro oferece aos usuários uma gama de recursos para começar a investir o mais rapidamente possível. Eles têm uma característica relativamente única chamada negociação de cópias, que lhe permite ganhar uma renda passiva ao espelhar comerciantes experientes, o que lhe permite começar a ter lucro rapidamente, e lhe dá uma melhor compreensão das estratégias usadas pelos profissionais. Além disso, o eToro permite aos usuários investir em carteiras administradas, sendo uma carteira administrada uma variedade de ativos semelhantes agrupados, permitindo ao senhor diversificar sua conta, reduzindo qualquer risco potencial. Para aqueles com experiência anterior em negociação, o senhor pode investir em mercados fora das ações, já que eToro permite aos usuários negociar ETFs, commodities, criptografia e índices. Se o senhor já investir fora do espaço da bolsa de valores, isso pode ser muito útil, pois permite ao senhor administrar todos os seus investimentos em um só lugar.
NuVasive’s management team includes the following people:
Mr. J. Christopher Barry, CEO & Director (Age 48, Pay $2.43M)
Mr. Nathaniel B. Sisitsky Esq., Sr. VP, Gen. Counsel & Corp. Sec. (Age 47, Pay $686.56k)
Mr. Matthew K. Harbaugh, Exec. VP & CFO (Age 51)
Mr. Dale A. Wolf, Sr. VP of Global Operations (Age 41)
Mr. Johnson Lai, Chief Information Officer
Mr. Sean Freeman, Sr. VP of Strategy & Corp. Devel.
Mr. Lucas Vitale, Sr. VP & Chief HR Officer (Age 44)
Mr. Frank Middeke, Managing Director of DACH
Ms. Lisa Pecora, VP & Head of Global Commercial Fin.
Mr. Brent J. Boucher, Exec. VP of Global Commercial (Age 54)
59 employees have rated NuVasive CEO Chris Barry on Glassdoor.com. Chris Barry has an approval rating of 88% among NuVasive’s employees.
Os CFDs são instrumentos complexos e vêm com um alto risco de perder dinheiro rapidamente devido à alavancagem. 68% de contas de investidores de varejo perdem dinheiro ao negociar CFDs com esse provedor. O senhor deve considerar se compreende como os CFDs funcionam, e se pode arcar com o alto risco de perder seu dinheiro.
Some companies that are related to NuVasive include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Intuitive Surgical (ISRG), Becton, Dickinson and (BDX), Boston Scientific (BSX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), Baxter International (BAX), DexCom (DXCM), ResMed (RMD), Hologic (HOLX), Teleflex (TFX), Insulet (PODD) and Varian Medical Systems (VAR).
View all of NUVA’s competitors.
Based on aggregate information from Reportlab watchlists, some companies that other NuVasive investors own include BioMarin Pharmaceutical (BMRN), Incyte (INCY), Puma Biotechnology (PBYI), Intel (INTC), Alibaba Group (BABA), (MDVN) (MDVN), Micron Technology (MU), Bank of America (BAC), Gilead Sciences (GILD) and Applied Materials (AMAT).
NuVasive trades on the NASDAQ under the ticker symbol “NUVA.”
NuVasive’s stock is owned by a number of retail and institutional investors. Top institutional shareholders include Victory Capital Management Inc. (2.09%), Fisher Asset Management LLC (1.84%), Scout Investments Inc. (0.98%), Fort Washington Investment Advisors Inc. OH (0.42%), Gamco Investors INC. ET AL (0.33%) and State of Wisconsin Investment Board (0.25%). Company insiders that own NuVasive stock include Gregory T Lucier, Matthew Link and Paul Mcclintock.
View institutional ownership trends for NuVasive.
1 | | Depósito mínimo $50 Promoção exclusiva | Nossa pontuação 10 ★★★★★ | 0% comissão |
NUVA stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Ziegler Capital Management LLC, SG Americas Securities LLC, State of Wisconsin Investment Board, Texas Permanent School Fund, Pacer Advisors Inc., New York State Teachers Retirement System, and California Public Employees Retirement System.
View insider buying and selling activity for NuVasive or view top insider-selling stocks.
NUVA stock was acquired by a variety of institutional investors in the last quarter, including Scout Investments Inc., Fort Washington Investment Advisors Inc. OH, Tower View Investment Management & Research LLC, Zurcher Kantonalbank Zurich Cantonalbank , Y Intercept Hong Kong Ltd, Gamco Investors INC. ET AL, Acorn Financial Advisory Services Inc. ADV, and IFP Advisors Inc.
View insider buying and selling activity for NuVasive or or view top insider-buying stocks.
Shares of NUVA can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Revisão dos Corretores Interativos, Revisão eToro, Revisão DEGiro, Revisão da AvaTrade, IG Markets Review, Revisão dos Mercados de IC, CMC Markets Review, Admiral Markets Review e muitos mais. Leia uma das revisões para saber tudo sobre o corretor e comece agora a comprar ações.
One share of NUVA stock can currently be purchased for approximately $58.61.
NuVasive has a market capitalization of $3.01 billion and generates $1.17 billion in revenue each year. The medical device company earns $65.23 million in net income (profit) each year or $2.47 on an earnings per share basis.
NuVasive employs 2,800 workers across the globe.
No Reportlab.org queremos garantir que o senhor tenha todas as informações mais relevantes sobre compra de ações. Trazemos-lhe os melhores guias sobre o mercado de ações, com revisões pessoais, informações de base, revisões de plataforma, como fazer e muito mais. Deseja obter outras informações? Então confira os Ações OTC, Ações da NASDAQ, Ações da NYSE, Ações LONES, Ações de FRA, Ações ETR, Ações da APE, Ações TSX ou Ações Amex. Procurando informações mais detalhadas como Ações de 5g, ações biotecnológicas, estoques de ouro e outras informações de nosso reportlab.
How can you buy NuVasive stock on the internet?
You can easily buy NuVasive stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Outra opção é usar um corretor regulamentado como Mercados de IC ou Corretores Interativos. You can an account with these brokers and start buying or trading NASDAQ:NUVA stocks in a safe and complete environment to trade in.
Where to buy NuVasive stock?
You will first want to find a licensed broker that supports NASDAQ:NUVA stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:NUVA stocks in a safe and complete environment.
Is NASDAQ:NUVA stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:NUVA stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is NuVasive stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:NUVA is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in NuVasive stock.
How do you trade NuVasive stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for NuVasive stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:NUVA stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell NuVasive stock?
To sell your NASDAQ:NUVA stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best NuVasive stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:NUVA stock.
Stephen sabe muito sobre produtos financeiros e, em particular, tem uma grande paixão pelas bolsas de valores e por seus participantes. Esperamos que a informação fornecida ajude o senhor. Algo não está muito claro? Queira deixar suas perguntas ou comentários no final da página.
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ | |
| Nossa pontuação ★★★★★ |
Boletim informativo
Notícias recentes
| |
Nossa pontuação |
0% comissão |
Top 10 Ações 5G Mais informações Ações 5G Top 10 Melhores Ações 5G Para Comprar
Ações em tempo real e dados criptográficos
Notificações, Dicas e Notícias
Melhores Ações e Guias Criptográficos
Corretor Online & Câmbio de Revisões
Reportlab Finanças é puramente um website informativo e em nenhum caso implica aconselhamento sobre investimentos. Todos os investimentos comportam riscos e o senhor pode perder todos os seus investimentos. Não invista dinheiro que o senhor não pode perder.
Reportlab Finanças
38 Holburn Lane
Heckfield Green
IP21 0UB
Reino Unido
Copyright © 2022 Reportlab.Finance | Todos os direitos reservados.
